Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer ; volume:15 ; number:1 ; day:24 ; month:10 ; year:2015 ; pages:1-10 ; date:12.2015
BMC cancer ; 15, Heft 1 (24.10.2015), 1-10, 12.2015
- Urheber
-
Earl, Julie
- Beteiligte Personen und Organisationen
-
Garcia-Nieto, Sandra
Martinez-Avila, Jose Carlos
Montans, José
Sanjuanbenito, Alfonso
Rodríguez-Garrote, Mercedes
Lisa, Eduardo
Mendía, Elena
Lobo, Eduardo
Malats, Nuria
Carrato, Alfredo
Guillén-Ponce, Carmen
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1779-7
- URN
-
urn:nbn:de:1111-2016110619295
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Earl, Julie
- Garcia-Nieto, Sandra
- Martinez-Avila, Jose Carlos
- Montans, José
- Sanjuanbenito, Alfonso
- Rodríguez-Garrote, Mercedes
- Lisa, Eduardo
- Mendía, Elena
- Lobo, Eduardo
- Malats, Nuria
- Carrato, Alfredo
- Guillén-Ponce, Carmen
- SpringerLink (Online service)
Ähnliche Objekte (12)
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
Circulating tumor DNA in Hodgkin lymphoma
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating Tumour DNA in Melanoma—Clinic Ready?
Liquid biopsy and circulating free plasma DNA
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Circulating tumor DNA moves further into the spotlight
Blood lipids influence DNA methylation in circulating cells
Analytical evaluation of circulating tumor DNA sequencing assays
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
Circulating tumor DNA in Hodgkin lymphoma
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating Tumour DNA in Melanoma—Clinic Ready?
Liquid biopsy and circulating free plasma DNA
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Circulating tumor DNA moves further into the spotlight
Blood lipids influence DNA methylation in circulating cells
Analytical evaluation of circulating tumor DNA sequencing assays
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
Circulating tumor DNA in Hodgkin lymphoma
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating Tumour DNA in Melanoma—Clinic Ready?
Liquid biopsy and circulating free plasma DNA
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Circulating tumor DNA moves further into the spotlight
Blood lipids influence DNA methylation in circulating cells